SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Neurocrine Biosciences (NBIX) -- Ignore unavailable to you. Want to Upgrade?

To: Torben Noerup Nielsen who wrote (464)1/21/2000 10:08:00 PM
From: Biotech Jim  Read Replies (1) | Respond to of 1834
 
www3.techstocks.com

www3.techstocks.com

With this kind of activity in NBIX, I guess that we will not need that fellowship for graduate school nor the stipend for medical school, pending the specific aspiration. Still have a few years to decide. Nice going all of you early birds. Nothing beats the analysis by the biotech experts here at SI. Congrats to all, but especially Miljenko on this one. the give and take has been outstanding. I now think that we will have at least two marketed drugs, and that is a minimal estimate. Not selling here yet.



To: Torben Noerup Nielsen who wrote (464)1/21/2000 10:59:00 PM
From: John Metcalf  Read Replies (1) | Respond to of 1834
 
Who is this Richard guy you folks keep talking about?

Many thanks from me, too. I am paying off the mortgage twenty-eight years early.

And many thanks to Miljenko, Biotech Jim, PB, rkrw, Peter Suzman, DAK, and the many others who have contributed here, and throughout SI Biotech.


HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News